These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1386131

  • 1. Improved heart failure protection by FK664, a novel positive inotropic agent, in dog heart-lung preparations.
    Sudo Y, Takai M, Esumi K.
    Life Sci; 1992; 51(6):PL41-6. PubMed ID: 1386131
    [Abstract] [Full Text] [Related]

  • 2. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T, Nunoki K, Satoh K, Taira N.
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [Abstract] [Full Text] [Related]

  • 3. Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
    Satoh K, Nunoki K, Goto T, Hosono M, Hashimoto H, Sato Y, Taira N.
    Jpn J Pharmacol; 1988 Jun; 47(2):189-95. PubMed ID: 3199595
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Postoperative cardiac insufficiency. The value of enoximone].
    Albo C, Baron JF, Coriat P, Souguir S, Viars P.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():87-93. PubMed ID: 2147841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E, Gonzalez M, Jacquemart JL, Collard P, Roulette F, Pourbaix S, Tremouroux J.
    Am J Cardiol; 1987 Aug 14; 60(5):46C-52C. PubMed ID: 2956868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
    Chatterjee K, Kereiakes D, Viquerat C, Podolin R.
    Am J Cardiol; 1987 Aug 14; 60(5):37C-41C. PubMed ID: 2956866
    [Abstract] [Full Text] [Related]

  • 13. Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
    Treese N, Erbel R, Rhein S, Henrichs KJ, Meyer J.
    Eur Heart J; 1989 Jun 14; 10(6):484-92. PubMed ID: 2527155
    [Abstract] [Full Text] [Related]

  • 14. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H.
    Z Kardiol; 1991 Jun 14; 80 Suppl 4():35-40. PubMed ID: 1833895
    [Abstract] [Full Text] [Related]

  • 15. Chronic therapy of severe heart failure with enoximone.
    Gilfrich HJ, Witzke-Gross J, Römer A.
    J Cardiovasc Pharmacol; 1989 Jun 14; 14 Suppl 1():S75-7. PubMed ID: 2480490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC, Roebel LE, Hsieh CP, Weiner DL, Woodward JK.
    J Cardiovasc Pharmacol; 1982 Jun 14; 4(3):500-8. PubMed ID: 6177949
    [Abstract] [Full Text] [Related]

  • 19. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK, Taylor D, Pilcher J.
    Circulation; 1987 Dec 14; 76(6):1307-11. PubMed ID: 2960473
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.